US Stock MarketDetailed Quotes

SONN Sonnet BioTherapeutic

Watchlist
  • 1.5100
  • +0.0200+1.34%
Close Dec 27 16:00 ET
  • 1.5300
  • +0.0200+1.32%
Post 19:56 ET
4.54MMarket Cap-0.13P/E (TTM)

Sonnet BioTherapeutic Key Stats

Sonnet BioTherapeutic Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 28.500K--
--2024/Q20.000 / 12.330K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 28.500K--
--2024/Q20.000 / 12.330K--

Unlock Free Earnings Estimates

Sonnet BioTherapeutic Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.